Feb 18, 2020   SOURCE: PR NewsWire

2020 Viscosupplementation Industry Report - Featuring Profiles of Anika Therapeutics, Bioventus, Chugai Pharma, Sanofi, Seikagaku, and More

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- The "Viscosupplementation: Global Market Overview" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The global viscosupplementation market is segmented by procedure type, application and region.

Growth of the global market is attributed to the growing prevalence of knee osteoarthritis, a strong product pipeline for single and Three-Injection cycle market segments and strong investment into research and development activities by key market players, including Seikagaku Corp., Anika Therapeutics Inc., Bioventus, Fidia Farmaceutici, and others.

Increasing patient preference for new, minimally-invasive viscosupplementation procedures comes with a substantial increase in the prevalence of knee osteoarthritis in the U.S.

The U.S. is one of the major markets for viscosupplements. According to the U.S. Arthritis Foundation, osteoarthritis is the most common type of arthritis. It affects nearly 30 million people in the U.S. The increased number of osteoarthritis patients is likely to drive the market for viscosupplementation during the forecast period.

The report includes:

    --  An overview of global viscosupplementation market
    --  Detailed market share of viscosupplementation based on product type,
        procedure type, injection cycle, and application
    --  Highlights of current and future market potential of
        viscosupplementation and a detailed analysis of the competitive
        environment, regulatory scenario, patent analysis, and drivers,
        challenges, and trends in market growth
    --  Knowledge about hyaluronic acid, a lubricating agent and discussion on
        how it enables smooth movement of bones
    --  Coverage of minimally invasive viscosupplementation procedures, new
        product innovations, and rapid product advancements
    --  Insights into strategic initiatives by major companies including
        partnerships, agreements, geographic expansions, R&D of products, new
        product launches, mergers and acquisitions and opportunities for the
        companies
    --  Company profiles of major global corporations within this market,
        including Anika Therapeutics Inc., Bioventus, Chugai Pharmaceuticals
        Co., Ltd., Sanofi and Seikagaku Corp.

Key Topics Covered

Chapter 1 Introduction

    --  Study Goals and Objectives
    --  Reasons for Doing This Study
    --  Scope of Report
    --  Information Sources
    --  Methodology
    --  Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

    --  Osteoarthritis
    --  Etiology
    --  Epidemiology and Market Burden
    --  Prevalence of Osteoarthritis
    --  Disease Symptoms
    --  Risk Factors
    --  Diagnosis
    --  Treatments
    --  Reducing the Risk of Osteoarthritis

Chapter 4 Market Dynamics

    --  Market Drivers
    --  Increasing Prevalence of Knee Osteoarthritis
    --  Growing Elderly Population
    --  Emerging Countries
    --  Minimally Invasive Procedures
    --  Market Restraints
    --  Substitute Treatment Options
    --  Intellectual Property
    --  Insurance Denials
    --  Government Regulations
    --  Market Opportunities
    --  Patient Preference
    --  Strategic Initiatives
    --  New Product Launches and R&D

Chapter 5 Market Breakdown by Procedure Type

    --  Global Market for Viscosupplementation by Procedure Type
    --  Three-Injection Cycle
    --  Single-Injection Cycle
    --  Five-Injection Cycle

Chapter 6 Market Breakdown by Application

    --  Global Market for Viscosupplementation by Application
    --  Knee Osteoarthritis
    --  Hip Osteoarthritis
    --  Other Applications (Shoulder and Ankle Osteoarthritis)

Chapter 7 Market Breakdown by Region

    --  Global Market for Viscosupplementation by Region
    --  North America
    --  United States
    --  Canada
    --  Europe
    --  UK
    --  Germany
    --  France
    --  Italy
    --  Spain
    --  Rest of Western Europe
    --  Eastern Europe
    --  Asia-Pacific
    --  Japan
    --  China
    --  India
    --  Australia
    --  South Korea
    --  Rest of Asia-Pacific
    --  Latin America
    --  Middle East and Africa

Chapter 8 Regulatory Structure: Medical Devices

    --  Regulatory Background
    --  Regulation of Medical Devices by Country/Region
    --  U.S.
    --  European Union (EU)
    --  Japan

Chapter 9 Competitive Landscape

    --  Global Company Market Share Analysis
    --  Mergers and Acquisitions
    --  Agreements, Contracts, Collaborations and Partnerships
    --  New Product Launches

Chapter 10 Company Profiles

    --  Major Viscosupplement Manufacturers
    --  Anika Therapeutics Inc.
    --  Bioventus
    --  Chugai Pharmaceutical Co. Ltd.
    --  Ferring B.V.
    --  Fidia Farmaceutici S.p.A.
    --  Sanofi
    --  Seikagaku Corp.
    --  Other Prominent Companies

For more information about this report visit https://www.researchandmarkets.com/r/dool2q

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/2020-viscosupplementation-industry-report---featuring-profiles-of-anika-therapeutics-bioventus-chugai-pharma-sanofi-seikagaku-and-more-301006602.html

SOURCE Research and Markets